Skip to main content

Advertisement

Log in

Sex-specific differences in the association between metabolically healthy overweight/obesity and the risk of hypertension in Chinese ethnic minorities

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Objective

To estimate and compare sex-specific differences between metabolically healthy overweight/obesity (MHOO) and the risk of hypertension among Dong, Bouyei, and Miao adults in southwest China.

Methods

MHOO was diagnosed when the patient had a body mass index ≥24 kg/m2 and the presence of ≤1 component of metabolic syndrome. The main outcome was the occurrence of hypertension after the diagnosis or measurement by a physician at the baseline survey. Multivariate logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) between MHOO and the risk of hypertension.

Results

We enrolled 16,433 Chinese Dong, Bouyei, and Miao adults. Using the metabolically healthy normal weight (MHNW) as a reference and after adjusting for confounders, the association between MHOO and the risk of hypertension was stronger in Dong (OR = 1.46, 95% CI: 1.07–2.00) and Miao (OR = 2.05, 95% CI: 1.48–2.85) men and did not exist in Bouyei men (OR = 1.14, 95% CI: 0.81–1.60). After adjusting for the age, the association between MHOO and the risk of hypertension was stronger in men than in women among Dong adults aged 30–59 years (OR = 1.64, 95% CI: 1.12–2.40) and did not differ between men and women among Dong adults aged 60–79 years or among Miao or Bouyei adults.

Conclusion

The results of this study demonstrated sex-specific differences in the association between MHOO and the risk of hypertension and that sex-specific differences further differed among Dong, Bouyei, and Miao adults.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. NCD Risk Factor Collaboration (NCD-RisC), Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 398(10304), 957–980 (2019). https://doi.org/10.1016/S0140-6736(21)01330-1

    Article  Google Scholar 

  2. J.F. Reckelhoff, Gender differences in hypertension. Curr. Opin. Nephrol. Hypertens. 27(3), 176–181 (2018). https://doi.org/10.1097/MNH.0000000000000404

    Article  CAS  PubMed  Google Scholar 

  3. J. Lu, Y. Lu, X. Wang, X. Li, G.C. Linderman, C. Wu, X. Cheng, L. Mu, H. Zhang, J. Liu, M. Su, H. Zhao, E.S. Spatz, J.A. Spertus, F.A. Masoudi, H.M. Krumholz, L. Jiang, Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet 390(10112), 2549–2558 (2017). https://doi.org/10.1016/S0140-6736(17)32478-9

    Article  PubMed  Google Scholar 

  4. S.S. Virani, A. Alonso, H.J. Aparicio, E.J. Benjamin, M.S. Bittencourt, C.W. Callaway, A.P. Carson, A.M. Chamberlain, S. Cheng, F.N. Delling, M. Elkind, K.R. Evenson, J.F. Ferguson, D.K. Gupta, S.S. Khan, B.M. Kissela, K.L. Knutson, C.D. Lee, T.T. Lewis, J. Liu; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation 143(8), e254–e743 (2021). https://doi.org/10.1161/CIR.0000000000000950

    Article  PubMed  Google Scholar 

  5. S. Lewington, B. Lacey, R. Clarke, Y. Guo, X.L. Kong, L. Yang, Y. Chen, Z. Bian, J. Chen, J. Meng, Y. Xiong, T. He, Z. Pang, S. Zhang, R. Collins, R. Peto, L. Li, Z. Chen; China Kadoorie Biobank Consortium, The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China. JAMA Intern. Med. 176(4), 524–532 (2016). https://doi.org/10.1001/jamainternmed.2016.0190

    Article  PubMed  Google Scholar 

  6. M.H. Forouzanfar, P. Liu, G.A. Roth, M. Ng, S. Biryukov, L. Marczak, L. Alexander, K. Estep, K. Hassen Abate, T.F. Akinyemiju, R. Ali, N. Alvis-Guzman, P. Azzopardi, A. Banerjee, T. Bärnighausen, A. Basu, T. Bekele, D.A. Bennett, S. Biadgilign, F. Catalá-López, C.J. Murray, Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA 317(2), 165–182 (2017). https://doi.org/10.1001/jama.2016.19043

    Article  PubMed  Google Scholar 

  7. K.T. Mills, A. Stefanescu, J. He, The global epidemiology of hypertension. Nat. Rev. Nephrol. 16(4), 223–237 (2020). https://doi.org/10.1038/s41581-019-0244-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. D. Susic, J. Varagic, Obesity: A Perspective from Hypertension. Med. Clin. North Am. 101(1), 139–157 (2017). https://doi.org/10.1016/j.mcna.2016.08.008

    Article  PubMed  Google Scholar 

  9. A. Engin, The Definition and Prevalence of Obesity and Metabolic Syndrome. Adv. Exp. Med. Biol. 960, 1–17 (2017). https://doi.org/10.1007/978-3-319-48382-5_1

    Article  CAS  PubMed  Google Scholar 

  10. M. Blüher, Metabolically Healthy Obesity. Endocr. Rev. 41(3), bnaa004 (2020). https://doi.org/10.1210/endrev/bnaa004

    Article  PubMed  PubMed Central  Google Scholar 

  11. D. Samocha-Bonet, V.D. Dixit, C.R. Kahn, R.L. Leibel, X. Lin, M. Nieuwdorp, K.H. Pietiläinen, R. Rabasa-Lhoret, M. Roden, P.E. Scherer, S. Klein, E. Ravussin, Metabolically healthy and unhealthy obese–the 2013 Stock Conference report. Obes. Rev. 15(9), 697–708 (2014). https://doi.org/10.1111/obr.12199

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. R.P. Wildman, P. Muntner, K. Reynolds, A.P. McGinn, S. Rajpathak, J. Wylie-Rosett, M.R. Sowers, The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch. Intern. Med. 168(15), 1617–1624 (2008). https://doi.org/10.1001/archinte.168.15.1617

  13. N. Stefan, K. Kantartzis, J. Machann, F. Schick, C. Thamer, K. Rittig, B. Balletshofer, F. Machicao, A. Fritsche, H.U. Häring, Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 168(15), 1609–1616 (2008). https://doi.org/10.1001/archinte.168.15.1609

    Article  PubMed  Google Scholar 

  14. N. Stefan, Causes, consequences, and treatment of metabolically unhealthy fat distribution. Lancet Diabetes Endocrinol. 8(7), 616–627 (2020). https://doi.org/10.1016/S2213-8587(20)30110-8

    Article  PubMed  Google Scholar 

  15. A. Mirzababaei, H. Mozaffari, S. Shab-Bidar, A. Milajerdi, K. Djafarian, Risk of hypertension among different metabolic phenotypes: a systematic review and meta-analysis of prospective cohort studies. J. Hum. Hypertens. 33(5), 365–377 (2019). https://doi.org/10.1038/s41371-018-0146-y

    Article  PubMed  Google Scholar 

  16. S.Y. Jae, A.S. Babu, E.S. Yoon, S. Kurl, J.A. Laukkanen, Y.H. Choi, B.A. Franklin, Impact of Cardiorespiratory Fitness and Risk of Systemic Hypertension in Nonobese Versus Obese Men Who Are Metabolically Healthy or Unhealthy. Am. J. Cardiol. 120(5), 765–768 (2017). https://doi.org/10.1016/j.amjcard.2017.05.054

    Article  PubMed  Google Scholar 

  17. S.K. Lee, S.H. Kim, G.Y. Cho, I. Baik, H.E. Lim, C.G. Park, J.B. Lee, Y.H. Kim, S.Y. Lim, H. Kim, C. Shin, Obesity phenotype and incident hypertension: a prospective community-based cohort study. J. Hypertens. 31(1), 145–151 (2013). https://doi.org/10.1097/HJH.0b013e32835a3637

    Article  CAS  PubMed  Google Scholar 

  18. M. Kuwabara, R. Kuwabara, I. Hisatome, K. Niwa, C.A. Roncal-Jimenez, P. Bjornstad, A. Andres-Hernando, Y. Sato, T. Jensen, G. Garcia, M. Ohno, J.O. Hill, M.A. Lanaspa, R.J. Johnson, “Metabolically Healthy” Obesity and Hyperuricemia Increase Risk for Hypertension and Diabetes: 5-year Japanese Cohort Study. Obes. (Silver Spring). 25(11), 1997–2008 (2017). https://doi.org/10.1002/oby.22000

    Article  CAS  Google Scholar 

  19. M. Fujita, A. Hata, Sex and age differences in the effect of obesity on incidence of hypertension in the Japanese population: A large historical cohort study. J. Am. Soc. Hypertens. 8(1), 64–70 (2014). https://doi.org/10.1016/j.jash.2013.08.001

    Article  PubMed  Google Scholar 

  20. K. Colafella, K.M. Denton, Sex-specific differences in hypertension and associated cardiovascular disease. Nat. Rev. Nephrol. 14(3), 185–201 (2018). https://doi.org/10.1038/nrneph.2017.189

    Article  PubMed  Google Scholar 

  21. M. Kabootari, S. Akbarpour, F. Azizi, F. Hadaegh, Sex specific impact of different obesity phenotypes on the risk of incident hypertension: Tehran lipid and glucose study. Nutr. Metab. (Lond.) 16, 16 (2019). https://doi.org/10.1186/s12986-019-0340-0

    Article  PubMed  Google Scholar 

  22. J.K. Yoo, Q. Fu, Impact of sex and age on metabolism, sympathetic activity, and hypertension. FASEB J. 34(9), 11337–11346 (2020). https://doi.org/10.1096/fj.202001006RR

    Article  CAS  PubMed  Google Scholar 

  23. J.M. Raison, A.M. Achimastos, M.E. Safar, Sex-dependence of body fat distribution in patients with obesity and hypertension. Clin. Exp. Hypertens. A 14(3), 505–525 (1992). https://doi.org/10.3109/10641969209036203

    Article  CAS  PubMed  Google Scholar 

  24. X. Zhao, F. Hong, J. Yin, W. Tang, G. Zhang, X. Liang, J. Li, C. Cui, X. Li; China Multi-Ethnic Cohort (CMEC) collaborative group, Cohort Profile: the China Multi-Ethnic Cohort (CMEC) study. Int J. Epidemiol. 50(3), 721–7211 (2021). https://doi.org/10.1093/ije/dyaa185

    Article  PubMed  Google Scholar 

  25. B.F. Zhou, Cooperative Meta-Analysis Group of the Working Group on Obesity in China, Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults–study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed. Environ. Sci. 15(1), 83–96 (2002)

    PubMed  Google Scholar 

  26. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, S.C. Smith Jr, International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16), 1640–1645 (2009). https://doi.org/10.1161/CIRCULATIONAHA.109.192644

    Article  CAS  PubMed  Google Scholar 

  27. M.B. Schulze, Metabolic health in normal-weight and obese individuals. Diabetologia 62(4), 558–566 (2019). https://doi.org/10.1007/s00125-018-4787-8

    Article  PubMed  Google Scholar 

  28. S. Tian, Y. Xu, H. Dong, The effect of metabolic health and obesity phenotypes on risk of hypertension: a nationwide population-based study using 5 representative definitions of metabolic health. Med. (Baltim.) 97(38), e12425 (2018). https://doi.org/10.1097/MD.0000000000012425

    Article  Google Scholar 

  29. Y. Zhao, P. Qin, H. Sun, Y. Liu, D. Liu, Q. Zhou, C. Guo, Q. Li, G. Tian, X. Wu, D. Hu, X. Sun, M. Zhang, Metabolically healthy general and abdominal obesity are associated with increased risk of hypertension. Br. J. Nutr. 123(5), 583–591 (2020). https://doi.org/10.1017/S0007114519003143

    Article  CAS  PubMed  Google Scholar 

  30. D.R. Young, H. Fischer, D. Arterburn, D. Bessesen, L. Cromwell, M.F. Daley, J. Desai, A. Ferrara, S.L. Fitzpatrick, M.A. Horberg, C. Koebnick, C.L. Nau, C. Oshiro, B. Waitzfelder, A. Yamamoto, Associations of overweight/obesity and socioeconomic status with hypertension prevalence across racial and ethnic groups. J. Clin. Hypertens. (Greenwich) 20(3), 532–540 (2018). https://doi.org/10.1111/jch.13217

    Article  CAS  PubMed  Google Scholar 

  31. R.J. Wong, C. Chou, S.R. Sinha, A. Kamal, A. Ahmed, Ethnic disparities in the association of body mass index with the risk of hypertension and diabetes. J. Community Health 39(3), 437–445 (2014). https://doi.org/10.1007/s10900-013-9792-8

    Article  PubMed  Google Scholar 

  32. H. Fan, X. Zhang, Effects of smoking intensity trajectory, cumulative smoking exposure, and the number of years since quitting on the subsequent risk of hypertension. J. Clin. Hypertens. (Greenwich) 24(7), 937–944 (2022). https://doi.org/10.1111/jch.14534

    Article  CAS  PubMed  Google Scholar 

  33. H.E. Badr, S. Rao, F. Manee, Gender differences in quality of life, physical activity, and risk of hypertension among sedentary occupation workers. Qual. Life Res. 30(5), 1365–1377 (2021). https://doi.org/10.1007/s11136-020-02741-w

    Article  PubMed  Google Scholar 

  34. F. Zhao, Q. Liu, Y. Li, X. Feng, H. Chang, J. Lyu, Association between alcohol consumption and hypertension in Chinese adults: Findings from the CHNS. Alcohol 83, 83–88 (2020). https://doi.org/10.1016/j.alcohol.2019.09.004

    Article  PubMed  Google Scholar 

  35. G. Navarro, C. Allard, W. Xu, F. Mauvais-Jarvis, The role of androgens in metabolism, obesity, and diabetes in males and females. Obes. (Silver Spring) 23(4), 713–719 (2015). https://doi.org/10.1002/oby.21033

    Article  CAS  Google Scholar 

  36. J.L. Faulkner, E.J. Belin de Chantemèle, Sex Differences in Mechanisms of Hypertension Associated With Obesity. Hypertension 71(1), 15–21 (2018). https://doi.org/10.1161/HYPERTENSIONAHA.117.09980

    Article  CAS  PubMed  Google Scholar 

  37. A.M. Kaneva, E.R. Bojko, Sex differences in the association between obesity and hypertension. Arch. Physiol. Biochem. 1–8 (2021). https://doi.org/10.1080/13813455.2020.1861027

  38. G. Seravalle, G. Grassi, Obesity and hypertension. Pharm. Res. 122, 1–7 (2017). https://doi.org/10.1016/j.phrs.2017.05.013

    Article  CAS  Google Scholar 

  39. M.T. Schütten, A.J. Houben, P.W. de Leeuw, C.D. Stehouwer, The Link Between Adipose Tissue Renin-Angiotensin-Aldosterone System Signaling and Obesity-Associated Hypertension. Physiol. (Bethesda) 32(3), 197–209 (2017). https://doi.org/10.1152/physiol.00037.2016

    Article  CAS  Google Scholar 

  40. G.F. DiBona, Sympathetic nervous system and hypertension. Hypertension 61(3), 556–560 (2013). https://doi.org/10.1161/HYPERTENSIONAHA.111.00633

    Article  CAS  PubMed  Google Scholar 

  41. Q. Fu, Sex differences in sympathetic activity in obesity and its related hypertension. Ann. N. Y Acad. Sci. 1454(1), 31–41 (2019). https://doi.org/10.1111/nyas.14095

    Article  PubMed  Google Scholar 

  42. L.J. Briant, N. Charkoudian, E.C. Hart, Sympathetic regulation of blood pressure in normotension and hypertension: when sex matters. Exp. Physiol. 101(2), 219–229 (2016). https://doi.org/10.1113/EP085368

    Article  CAS  PubMed  Google Scholar 

  43. L.E. Taylor, J.C. Sullivan, Sex differences in obesity-induced hypertension and vascular dysfunction: a protective role for estrogen in adipose tissue inflammation? Am. J. Physiol. Am. J. Physiol. Regul. Integr. Comp. Physiol. 311(4), R714–R720 (2016). https://doi.org/10.1152/ajpregu.00202.2016

    Article  Google Scholar 

  44. S.C. Chen, T.C. Lo, J.H. Chang, H.W. Kuo, Variations in aging, gender, menopause, and obesity and their effects on hypertension in taiwan. Int J. Hypertens. 2014, 515297 (2014). https://doi.org/10.1155/2014/515297

    Article  PubMed  PubMed Central  Google Scholar 

  45. J.H. Ryoo, S.K. Park, C.M. Oh, Y.J. Choi, J.Y. Chung, W.T. Ham, T. Jung, Evaluating the risk of hypertension according to the metabolic health status stratified by degree of obesity. J. Am. Soc. Hypertens. 11(1), 20–27.e4 (2017). https://doi.org/10.1016/j.jash.2016.10.006

    Article  PubMed  Google Scholar 

  46. Y.M. Kang, C.H. Jung, J.E. Jang, J.Y. Hwang, E.H. Kim, J.Y. Park, H.K. Kim, W.J. Lee, The association of incident hypertension with metabolic health and obesity status: definition of metabolic health does not matter. Clin. Endocrinol. (Oxf.) 85(2), 207–215 (2016). https://doi.org/10.1111/cen.13074

    Article  CAS  PubMed  Google Scholar 

  47. S.K. Lee, S.H. Kim, G.Y. Cho, I. Baik, H.E. Lim, C.G. Park, J.B. Lee, Y.H. Kim, S.Y. Lim, H. Kim, C. Shin, Obesity phenotype and incident hypertension: a prospective community-based cohort study. J. Hypertens. 31(1), 145–151 (2013). https://doi.org/10.1097/HJH.0b013e32835a3637

    Article  CAS  PubMed  Google Scholar 

  48. C. Iacobini, G. Pugliese, C. Blasetti Fantauzzi, M. Federici, S. Menini, Metabolically healthy versus metabolically unhealthy obesity. Metabolism 92, 51–60 (2019). https://doi.org/10.1016/j.metabol.2018.11.009

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The investigators are grateful to the dedicated participants and all research staff of the study. The project was supported with the National Key R&D Program of China, Grant/Award Number: 2017YFC0907301 and the Science and Technology Plan Project of Guizhou Province, China: QKHPTRC [2018]5403.

Funding

This work was supported by the National Key R&D Program of China, Grant/Award Number: 2017YFC0907301 and the Science and Technology Plan Project of Guizhou Province, China: QKHPTRC [2018]5403.

Author information

Authors and Affiliations

Authors

Contributions

All the authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by X.W., Q.Z., N.M., L.P., L.L. The first draft of the paper was written by X.W., and all authors commented on previous versions of the paper. The authors have read and approved the final paper.

Corresponding authors

Correspondence to Feng Hong or Yuyan Xu.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Ethics approval and consent to participate

Approvals were given by the following organizations and institutes: the Sichuan University Medical Ethical Review Board (K2016038) and the research ethics committee of the Affiliated Hospital of Guizhou Medical University (2018[094]). Prior to the study, all the participants had read and signed informed consent.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, X., Zeng, Q., Ma, N. et al. Sex-specific differences in the association between metabolically healthy overweight/obesity and the risk of hypertension in Chinese ethnic minorities. Endocrine 80, 317–327 (2023). https://doi.org/10.1007/s12020-023-03308-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-023-03308-8

Keywords

Navigation